Affiliation:
1. Postgraduate, Thanjavur Medical College
2. MD, Associate Professor, Thanjavur Medical College
Abstract
Background: During the COVID pandemic, the burden of mucormycosis raised drastically. However, the exact prevailing picture of
mucormycosis was not broadly studies in South Indian population. Hence this study was conducted to determine the clinical prole of
mucormycosis cases in a tertiary care hospital. Methodology: This study was conducted as a cross sectional study in the Department of general
medicine in Thanjavur Medical College and hospital, Thanjavur, a tertiary care Government teaching hospital during the period of October 2020 to
August 2021. All patients with mucormycosis from both genders were included in the study. A total of 275 mucormycosis cases were included in
the study. Results: In this study among 275 cases with mucormycosis, 58.5% of cases remains positive for COVID 19 and common type of
mucormycosis were rhinocerebral type. The common risk factor noted was diabetes. All cases were treated with medical management however
FESS was the common surgery performed. Conclusion: We infer that during COVID 19 pandemic times, mucormycosis should be strongly
suspected in cases with COVID19 infections and among diabetes cases and vice versa
Subject
General Medicine,Psychiatry and Mental health,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine,Family Practice,Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,General Medicine,General Medicine,Care Planning,Public Health, Environmental and Occupational Health,Animal Science and Zoology,Nature and Landscape Conservation,Animal Science and Zoology,Ecology, Evolution, Behavior and Systematics
Reference30 articles.
1. Chen T, Dai Z, Mo P, Li X, Ma Z, Song S, Chen X, Luo M, Liang K, Gao S, Zhang Y. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: a single-centered, retrospective study. The Journals of Gerontology: Series A. 2020 Sep;75(9):1788-95.
2. Website of Ministry of Health and Family welfare, Government of India websitewww.mohfw.gov.in [Accessed 22 August 2022].
3. The Tribune. US CDC classifies delta variant as a variant of concern. https://www.tribuneindia.com/news/world/us-cdc-classifies-delta-variant-as-variant-of-concern-269825 [Accessed 17 October 2022]
4. Yang Wan, Shaman Jeffrey. COVID-19 pandemic dynamics in India and impactof the SARS-CoV-2 Delta (B.1.617.2): COVID-19 SARS-CoV-2 preprints frommedRxiv; 2021
5. Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus diseasemucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol2021;(April):1–6